Congenital Neutropenia Clinical Trial
Official title:
Identification of the Molecular Bases of Syndromic Congenital Neutropenia With Development Anomalies
Syndromic congenital neutropenia (SCN) includes a heterogeneous group of diseases
characterized by congenital neutropenia associated with the involvement of other organs.
Most patients have syndromic congenital neutropenia, which does not correspond, either
clinically or genetically, to any other previously described form. A large number of genes
still have to be identified in these syndromic forms.
The aim of this study is to identify the molecular bases of congenital neutropenias that
have not yet been classified, by taking advantage of high-throughput exome sequencing.
n/a
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03333486 -
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
|
Phase 2 |